UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.     )

 

Filed by the Registrant  ý

 

Filed by a Party other than the Registrant  o

 

Check the appropriate box:

o

Preliminary Proxy Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

o

Definitive Proxy Statement

o

Definitive Additional Materials

ý

Soliciting Material Pursuant to §240.14a-12

 

Specialty Laboratories, Inc.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

ý

No fee required.

o

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

(1)

Title of each class of securities to which transaction applies:

 

 

 

 

(2)

Aggregate number of securities to which transaction applies:

 

 

 

 

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

 

 

(4)

Proposed maximum aggregate value of transaction:

 

 

 

 

(5)

Total fee paid:

 

 

 

o

Fee paid previously with preliminary materials.

o

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

(1)

Amount Previously Paid:

 

 

 

 

(2)

Form, Schedule or Registration Statement No.:

 

 

 

 

(3)

Filing Party:

 

 

 

 

(4)

Date Filed:

 

 

 

 

 

Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 



 

SPECIALTY LABORATORIES, INC.

27027 Tourney Road

Valencia, CA 91355

 

January 10, 2006

 

To our Stockholders:

 

We have previously sent to you proxy material for the important special meeting of stockholders of Specialty Laboratories, Inc. (“Specialty”), to be held on January 30, 2006.  Specialty’s board of directors recommends that you vote FOR both items on the agenda.

 

Approval of the merger requires the affirmative vote of a majority of both the outstanding shares and the shares not held by continuing investors and their affiliates.  Your vote is important, no matter how many or how few shares you may own.  Whether or not you have already done so, please vote TODAY by signing, dating and returning the enclosed proxy card in the envelope provided.

 

Very truly yours,

 

 

Nicholas R. Simmons

Senior Vice-President & General Counsel and Inspector of Elections

 

REMEMBER:

If you hold your shares through a bank or broker,
you can vote your shares by telephone, or via the Internet.
Please follow the easy instructions on the enclosed card.

 

If you have any questions, or need assistance in voting
your shares, please call our proxy solicitor,

 

INNISFREE M&A INCORPORATED

TOLL-FREE, at 1-888-750-5834.